APPLICATION
NDA209529
TYPE
NDA
ORIGINAL APPROVAL
2020-05-26
LATEST ACTION
2020-05-26
ROUTE
ORAL
DOSAGE FORM
SUSPENSION
MARKETING STATUS
Discontinued
Products
VESICARE LS · ReferenceDiscontinued
SOLIFENACIN SUCCINATE 1MG/ML · SUSPENSION · ORAL
Approval history
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.